Comment: In banking and bank regulatory law, this leading firm stands out for its broad spectrum of high-end activity covering restructuring, M&A transactions and litigation. This was shown in work for UBS involving the simultaneous merger of four European subsidiaries into UBS Deutschland, which called for precise timing, and its subsequent conversion into an SE. Advice to London Stock Exchange on the repeated, albeit unsuccessful, attempts to merge with Deutsche Börse underlines the trust enjoyed by the regulatory practice in cooperation with the ?corporate lawyers for delicate and high-profile matters. Because of its experience and expertise, FBD is advising financial institutes on adjusting their structures to potential Brexit scenarios.
Strengths: Strong regulatory expertise; flexible and homogeneous cooperation with other practices.
Recommended: Dr. Gunnar Schuster (“a point of reference in the market”, competitor), Dr. Alexander Glos (“foremost players”, competitor on both), Dr. Benedikt Wolfers (public law), Dr. Patrick Cichy (“very sound”, client; corporate/M&A), Dr. Thomas Emde.
Practice: Comprehensive regulatory practice: mergers, portfolio transactions, advice on equity capital products, outsourcing, bank startups, fintech. Close integration between ?compliance audits and investigations, ?commercial litigation and liability and government-/institution-related advice, incl. ?state aid law. Frequently active in ?M&A for banks. ?Tax. (Core team: 3 partners, 1 counsel, 13 associates)
Clients: ?? UBS on simultaneous merger of 4 European subsidiaries into UBS Deutschland and change into SE; LSE on unsuccessful merger with Deutsche Börse; HSH Nordbank on sale of €5bn portfolio of bad ship loans and bid process for bank privatization; 7 US banks on plans to wind up German subsidiaries or branches; ADAC on cash pooling, investment/receivables management.
  • Teilen